Britt-Marie Landgren

No ORCID on file · 8 papers in corpus
article 2008
·doi:10.1016/j.fertnstert.2008.04.010

ObjectiveTo study the expression of leukemia inhibitory factor (LIF), its receptors LIFR and gp130, and its inhibitor SOCS1 in endometria from fertile women and infertile women with unexplained infertility. Signaling through the LIF pathway…

article 2005
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/j.0001-6349.2005.00558.x

Background. The effect of physical training on bone mineral density (BMD) in women with endometriosis treated with gonadotropin‐releasing hormone (GnRH) analogs was studied. Methods. Nineteen Caucasian premenopausal women aged 23–38 years w…

article 2005
·doi:10.1080/j.0001-6349.2005.00558.x
article 1985
·doi:10.1016/0002-9378(85)90304-7

A prostaglandin synthetase inhibitor, naproxen, was given continuously throughout the menstrual cycle at a dose of 250 mg twice daily to 10 healthy fertile women (group 1) and at a dose of 1000 mg per day to eight women in the secretory pha…

article 1983
·doi:10.1097/00006254-198303000-00015

Since the establishment of the classic system of Noyes et al. for dating endometrial biopsy specimens, more than 30 years ago, a plethora of data has been accumulated indicating the usefulness of this method. On the other hand, there are re…

article 1982
·doi:10.1016/0010-7824(82)90132-9

The pharmacokinetic and pharmacodynamic effects of vaginal devices releasing levonorgestrel (L-NOG) at a constant rate (in vitro release: approximately 20 micrograms/day) were studied in a group of 20 normally menstruating women during a pe…

article 1981
·doi:10.1016/0010-7824(81)90066-4
article 1979
·doi:10.1016/0010-7824(79)90020-9